Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
FDA removes hurdle to CAR T-cell therapies
The body is eliminating of Risk Evaluation and Mitigation Strategies for all currently approved BCMA- and CD19-directed CAR T-cell therapies.
Read more
Elon Musk's Neuralink inserts brain implant into second patient
Elon Musk’s Neuralink has implanted its brain implant into a new patient, making them the second person to take part in the trial.
Spotlight: July 2024
Catch up on the top pharma news stories of July in EMJ GOLD’s monthly round-up, including insights on pharma’s use of social media.
Eli Lilly’s weight loss drug shows promise in heart failure
The weight loss drug reduces the risk of hospitalisation, death and more for adults with obesity and a common form of heart failure.
BMS boss reacts to soon-to-be-announced IRA prices
BMS has been a vocal opponent of drug price negotiations under the US’ Inflation Reduction Act, but a price preview may have allayed fears.
Labour government to allow researchers broader access to NHS data
Researchers and pharmaceutical companies could get wider access to NHS data for the first time under new Labour plans.
WHO launches avian flu vaccine initiative for LMICs
With avian influenza posing an ongoing public health threat, a new initiative has been launched to better prepare low- and middle-income countries.
New haemophilia A treatment superior to current standard of care
Pfizer’s new gene therapy for haemophilia A has been found to significantly reduce the number of annual bleeding events in patients with the disorder.
Agilent Technologies acquires Biovectra for $925m
Agilent Technologies has announced the acquisition of contract drug manufacturing company Biovectra to expand its offerings to biotech companies and medical researchers.
Loading posts...
« Previous
1
…
18
19
20
21
22
…
30
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View